SkySpam1 schreef:
[quote=ludwig mack]
in de tekst staat dat ze wat meer i.p. moesten doen: wordt niet p.r. bedoeld ?
gr
[/quote]
Ik bedoel dat ze hun IP wat (veel) meer moeten uitvergroten, naar analogie van bijvoorbeeld:
"Protexia® has the potential to be an important biodefense product," stated Geoffrey F. Cox, Ph.D., GTC's Chairman of the Board and Chief Executive Officer. "We are pleased to be able to license our Intellectual Property for the development of Protexia®."
Alsook:
The allowed claims, which are expected to issue in the next several weeks, include all classes of proteins in all mammals and will provide GTC with a strong Intellectual Property position regarding the development and use of this technology for US markets. The patent that is expected to issue from this application will not expire until 2021.
"GTC has an extensive Intellectual Property portfolio for the production of therapeutic proteins in milk and we will continue to use our broad IP position to encourage the adoption of transgenic production technology by our collaborators and partners," stated Geoffrey F. Cox, Ph.D., GTC's Chairman and Chief Executive Officer. "This broad patent will provide long term protection for GTC's proprietary products in the USA, including our lead program for ATryn®."
En misschien (zoals reeds aangegeven door contoverse)
is de Europese markt voor ATryn® dan wel niet zo groot, maar kan de launch toch de ijsbreker en trendzetter voor de toekomst zijn !!?